Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001062993-14-002104
Filing Date
2014-04-11
Accepted
2014-04-11 16:45:48
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1 forms1.htm S-1 1317132
2 EXHIBIT 5.1 exhibit5-1.htm EX-5.1 4643
3 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1240
4 EXHIBIT 23.2 exhibit23-2.htm EX-23.2 1246
11 GRAPHIC forms1x3x1.jpg GRAPHIC 3197
12 GRAPHIC bdo.gif GRAPHIC 1373
  Complete submission text file 0001062993-14-002104.txt   14007024

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE avxl-20131231.xml EX-101.INS 1203540
6 XBRL SCHEMA FILE avxl-20131231.xsd EX-101.SCH 411963
7 XBRL CALCULATION FILE avxl-20131231_cal.xml EX-101.CAL 45484
8 XBRL DEFINITION FILE avxl-20131231_def.xml EX-101.DEF 951448
9 XBRL LABEL FILE avxl-20131231_lab.xml EX-101.LAB 2744412
10 XBRL PRESENTATION FILE avxl-20131231_pre.xml EX-101.PRE 1051484
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-1 | Act: 33 | File No.: 333-195225 | Film No.: 14760541
SIC: 8731 Services-Commercial Physical & Biological Research